However, persistent pain, swelling, or signs of infection at an injection site warrant communication with your healthcare provider
In this issue of Diabetologia , Hogan and colleagues report an improvement of psoriasis in three obese patients with type 2 diabetes several weeks after the initiation of therapy with the glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists exenatide and liraglutide [2]
L- ,
In another study, alogliptin intervention for 3 months improved vasodilation in obesity-induced autophagy in C57BL/6 mice
shipping just took a day longer than expected
Notably, type 2 diabetes often accelerates kidney function decline even before the onset of AKI, emphasizing the combined influence on CKD development 7,8,9,10